The study for the efficacy of rikkunshito on anorexia in the patients who underwent laparoscopy assisted gastrectomy and open gastrectomy

The study for the efficacy of rikkunshito on anorexia in the patients who underwent laparoscopy assisted gastrectomy and open gastrectomy - The efficacy of rikkunshito on anorexia after gastrectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008564

Enrollment

Registered

2012-07-31

Start date

2012-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer patient who underwent laparoscopy assisted gastrectomy or open gastrectomy

Interventions

Oral administration of rikkunshito (2.5g t.i.d) before or between meals for 12 months Standard treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Clinical Stage: IA-IIIA 2) Laparoscopy assisted gastrectomy or Open gastrectomy 3) ECOG Performance Score 0- 1 4) Aged 20 to 85 years old 5) Signed informed consent

Exclusion criteria

Exclusion criteria: 1) Patients who underwent total gastrectomy 2) Patients with history of radiotherapy to the abdomen 3) Patients scheculed to be under postoperative artificial respiration after surgery 4) Patients with inflammatory bowel disease (ulcerative colitis, Crohn disease) (including anamnestic case) 5) Patients with multiple cancer 6) Patients with synchronous colon resection 7) Patients whose main organ function is not working 8) Patients with history of laparotomy and peritonitis (excludeing surgery for appendicitis) 9) Patients who had administration of other Kampo medicine 4 weeks prior to the administration of test drug 10) Patients who are pregnant, considering pregnancy or lactating 11) Patients considered inappropriate by the study investigator

Design outcomes

Primary

Measure	Time frame
Variance analysis in clinical pathway	—

Secondary

Measure	Time frame
1) Body weight 2) Gastrointestinal symptom(anorexia) 3) Inflammation 4) Fever 5) Postoperative first flatus 6) Anemia	—

Countries

Japan

Contacts

Public ContactTakeharu Enomoto

St.Marianna University School of Medicine Hospital Department of Gastroenterological and General Surgery

takeharu@marianna-u.ac.jp044-977-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026